The leading trade group for the British biotech industry - the UK BioIndustry Association (BIA) - has published new figures showing that the sector raised a record £2.2 billion ($2.9 billion) last year, up from the £1.2 billion it raised in 2017.
BIA has also produced a report - Confident capital: backing UK biotech - providing further details of the performance of the sector over the most recent period.
The report finds that over £1.1 billion of venture capital was invested into UK biotech companies, and over £1 billion was raised on public markets in 2018. Across Europe, UK companies accounted for 40% of all biotech venture capital raised and 45% of funding raised through IPOs.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze